PharmaVOICE Blog Post

What does being ‘patient-centric’ in pharma really mean?

Posted By: Dan Limbach
February 22, 2021

Register now http://bit.ly/IQVIAFeb2021-blog

The COVID-19 pandemic has disrupted many aspects of life on a global scale. As disruptions often do, it also has accelerated the implementation of solutions that might otherwise still be waiting their turn as future ‘nice-to-haves.’ In 2020, digital transformation of customer engagement was accelerated across the industry, and we expect this to continue in 2021.

For some pharmaceutical companies, the path toward multi-channel customer engagement has meant pushing more teams to adopt existing remote tools or switching from face-to-face to virtual meetings. For others, the transformation has spurred providers to create capabilities from scratch. For a few, this time has presented an opportunity to make leaps previously considered experimental.

In this webinar series, Connecting to the Future of Customer Engagement, we will share what we have learned from the adaptations made by those leading the industry and discuss the most significant trends, local leader influence, patient community management, and incremental improvements for agility.

In this Webinar

Patient centricity has become a common theme for both internal- and external-facing communications within pharma companies in recent years. Even though adoption of this terminology has generated plenty of projects and branded communications, the interpretation of the statement continues to be a source of confusion, with limited understanding of its practical implications.

In this session, we will discuss a vision for transforming patient centricity into a clearly agreed-upon approach that can unify planning and execution of a strategy for new pharmaceutical product launches, and perhaps even change approaches for existing patient therapies.

Topics We Will Cover

  • Maximizing value of therapeutics by better understanding patients and their behaviors
  • Orchestrated Patient Engagement

Speakers

António Pregueiro
VP Life Science and Practice Lead
IQVIA

Dr. António Pregueiro is part of IQVIA’s Customer Engagement Center of Excellence. António’s experience spans both pharma and consulting, having worked in strategic marketing, commercial operations, and analytics.

 

 

Martin Collyer
Global Head, Orchestrated Patient Engagement
IQVIA

Martin Collyer is the Global Head of Orchestrated Patient Engagement for IQVIA. He has over 20 years of experience in the life sciences industry with broad expertise in patient engagement, medical communications, and clinical research.

 

Register now http://bit.ly/IQVIAFeb2021-blog

About the Blog Poster: Dan Limbach

Post a Comment

You must be logged in to post a Comment.

FEEDBACK